Loading…
კომპანიის ძირითად საქმიანობას წარმოადგენს საბითუმო ვაჭრობა ფარმაცევტული საქონლით და ჯანდაცვის სხვა საქმიანობები;
Subsidiary of Shezghuduli Pasukhismgeblobis Sazogadoeba Quest 100 Biosciences LLC (100.0%)
| Line item | 2023 | 2024 | CAGR |
|---|---|---|---|
| 1,363 | 3,202 | +134.9% | |
| Total COGS | 815 | 403 | -50.5% |
| Gross Profit | 549 | 2,799 | +410.0% |
| Gross Margin | 40.3% | 87.4% | |
| 482 | 1,759 | +265.2% | |
| EBITDA | 67 | 1,040 | +1447.3% |
| EBITDA Margin | 4.9% | 32.5% | |
| Total D&A | 67 | 146 | +119.5% |
| EBIT / Operating Income | 1 | 894 | nmf |
| Total Interest Income | 9 | 0 | |
| Total Interest Expense | 59 | 65 | +11.1% |
| 0 | 3 | ||
| Profit Before Tax | 50 | 825 | nmf |
| Total Income Tax | 0 | 0 | |
| Net Profit / (Loss) | 50 | 825 | nmf |
| Net Margin | 3.6% | 25.8% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set.